AML Pathogenesis and Therapy: A Scientific Symposium in Honor of Dr. Eli Estey

Scientific Symposium in Honor of Dr. Eli Estey

Dr. Eli Estey specialized in the treatment of acute myeloid leukemia (AML). 

Registration is now closed.

Featured Presenters

  • Jorge Cortes, MD, Georgia Cancer Center
  • John DiPersio, MD, PhD, Washington University School of Medicine
  • Sergei Doulatov, PhD, University of Washington
  • Benjamin Ebert, MD, PhD, Dana Farber Cancer Institute, Harvard University
  • Lucy Godley, MD, PhD, Northwestern University
  • Christopher Hourigan, MD, DPhil, NHLBI, National Institutes of Health
  • Mary-Beth Percival, MD, University of Washington & Fred Hutchinson Cancer Center
  • David Scadden, MD, Massachusetts General Hospital, Harvard University
  • Charles Schiffer, MD, Wayne State University
Date:
Friday, May 19, 2023
Start Time:
8 a.m. PDT
Location:
Seattle, Washington
Contact Information:

Sponsored By

Cancer Consortium and NCI Logo

Dr. Eli Estey Symposium Speakers

Mary-Beth Percival, MD

Talk Title: Clinical Research in AML: Challenges and Opportunities

Benjamin Ebert, MD, PhD

Talk Title: Clinical Research in AML: Challenges and Opportunities

Christopher Hourigan, MD, DPhil.

Talk Title: Why Measure?

David Scadden, MD

Talk Title: Microenvironments and AML

Sergei Doulatov, PhD

Talk Title: Evolution of AML with complex karyotype

Lucy Godley, MD, PhD

Talk Title: Germline predisposition to hematopoietic malignancies

Charles Schiffer, MD

Talk Title: The Challenge of AML in “Olderly” People

Jorge Cortes, MD

Talk Title: IDH1 inhibitors for AML: is olutasidenib a valuable addition?

John DiPersio, MD, PhD

Talk Title: Current State of Immunotherapy for AML and Future Directions

Agenda and Speakers

campus image

Contact Us

This symposium is sponsored by the Office of Faculty Affairs and Diversity